| Literature DB >> 29911326 |
François Thiaucourt1, Olivier Pible2, Guylaine Miotello2, Nick Nwankpa3, Jean Armengaud2.
Abstract
Vaccines to protect livestock against contagious caprine pleuropneumonia (CCPP) consist of inactivated, adjuvanted antigens. Quality control of these vaccines is challenging as total protein quantification provides no indication of protein identity or purity, and culture is not an option. Here, a tandem mass spectrometry approach is used to identify the mycoplasma antigen contained in reference samples and in commercial CCPP vaccines. By the same approach, the relative amounts of mycoplasma antigen and residual proteins originating from the production medium are determined. Mass spectrometry allows easy and rapid identification of the peptides present in the vaccine samples. Alongside the most probable mycoplasma species effectively present in the vaccines, a very high proportion of peptides from medium constituents are detected in the commercial vaccines tested.Entities:
Keywords: contagious caprine pleuropneumonia; mass spectrometry; quality control; vaccines
Mesh:
Substances:
Year: 2018 PMID: 29911326 DOI: 10.1002/pmic.201800088
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 3.984